Blockchain Registration Transaction Record

NHS Rolls Out One-Minute Cancer Immunotherapy Jab

NHS rolls out one-minute immunotherapy jab for thousands of cancer patients, replacing hours-long infusions. Learn how this upgrade impacts treatment and companies like Calidi Biotherapeutics.

This news matters because it represents a major improvement in patient experience and healthcare efficiency. The transition from lengthy intravenous infusions to a one-minute injection for pembrolizumab reduces hospital stay times, lowers treatment burden on patients, and allows the NHS to treat more patients with the same resources. It also signals a broader trend in oncology toward more convenient and less invasive administration methods, which could accelerate adoption of immunotherapies and improve outcomes for cancer patients worldwide.